IP Library Granted Patent US 7,160,691
Granted Patent B2
US 7,160,691 · App. 10/353,090 · Granted Jan 9, 2007

Protein fragment complementation assays for the detection of biological or drug interactions

Assignee: Odyssey Thera Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,160,691
App. No.
10/353,090
Granted
Jan 9, 2007
Kind
B2
Abstract

The present invention describes a method for detecting biomolecular interactions said method comprising: (a) selecting an appropriate reporter molecule selected from the group consisting of a protein, a fluorescent protein, a luminescent protein and a phosphorescent protein; (b) effecting fragmentation of said reporter molecule such that said fragmentation results in reversible loss of reporter function; (c) fusing or attaching fragments of said reporter molecule separately to other molecules; followed by (d) reassociation of said reporter fragments through interactions of the molecules that are fused to said fragments; and (e) detecting said biomolecular interactions by reconstitution of activity of the reporter molecule.

Claims (1)

1. Protein fragment complementation assays for the detection of molecular interactions comprising a reassembly of separate fragments of luciferase, wherein reassembly of said luciferase fragments is operated by the interaction of molecular domains fused to each luciferase fragment, wherein reassembly of the luciferase fragments is independent of other molecular processes and wherein said reassembly is detected by means of reconstitution of activity of said luciferase.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2016
From: WATSON MICHNICK, STEPHEN WILLIAM; PELLETIER, JOELLE NINA; REMY, INGRID
To: THE UNIVERSITY OF MONTREAL
Reel/Frame 038020/0612 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2016
From: THE UNIVERSITY OF MONTREAL
To: EXIGEN PHARMACEUTICALS
Reel/Frame 038020/0636 →
AMENDMENT TO THE ARTICLES OF INCORPORATION Recorded Mar 18, 2016
From: EXIGEN PHARMACEUTICALS, INC.
To: ODYSSEY PHARMACEUTICALS, INC.
Reel/Frame 038146/0812 →
MERGER Recorded Mar 18, 2016
From: ODYSSEY PHARMACEUTICALS, INC.
To: ODYSSEY THERA, INC.
Reel/Frame 038146/0834 →
Priority Claims (1)
CA 2196496 · Jan 31, 1997 · national
Continuity (4)
Continuation 1015475800 · May 24, 2002
Division 0949946400 · Feb 7, 2000
Division 0901741200 · Feb 2, 1998
Related Publication 20040038298A1 · Feb 26, 2004